FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease Mário Reis Álvares-da-Silva; Márcia da Silva Vargas; Soheyla Mohd Souza Rabie; Gabriella Jonko; Patricia Gabriela Riedel; Larisse Longo; Marcelo Rodrigues Gonçalves; Vivian Cristine Luft; Dvora Joveleviths;

Soft drink consumption and increased risk of nonalcoholic fatty liver disease: Results from the health workers cohort study Edgar Denova-Gutiérrez; Berenice Rivera-Paredez; Amado D. Quezada-Sánchez; Brianda I. Armenta-Guirado; Paloma Muñoz-Aguirre; Yvonne N. Flores; Rafael Velázquez-Cruz; Jorge Salmerón;

Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c Hirsh D. Trivedi; Qua Tran; Zachary Fricker; Michael P. Curry; Jonathan X. Li; Michelle Lai;